Zhang L, Li J, Wang Z, Yang L, Chen Z, Tao F
BMC Pediatr. 2024; 24(1):802.
PMID: 39643863
PMC: 11622451.
DOI: 10.1186/s12887-024-05243-7.
Chen Y, Jiang Q, Xue Y, Chen W, Hua M
Funct Integr Genomics. 2024; 24(4):125.
PMID: 38995475
DOI: 10.1007/s10142-024-01399-8.
Zeng Z, Fu M, Hu Y, Wei Y, Wei X, Luo M
Mol Cancer. 2023; 22(1):172.
PMID: 37853437
PMC: 10583419.
DOI: 10.1186/s12943-023-01877-w.
Lux S, Milsom M
Hemasphere. 2023; 7(10):e959.
PMID: 37810550
PMC: 10553128.
DOI: 10.1097/HS9.0000000000000959.
Cheng C, Hong W, Li Y, Xiao X, McKay J, Han Y
J Thorac Oncol. 2023; 18(8):1003-1016.
PMID: 37150255
PMC: 10435278.
DOI: 10.1016/j.jtho.2023.05.001.
Comprehensive overview of the role of PBX1 in mammalian kidneys.
Zou F, Liu M, Sui Y, Liu J
Front Mol Biosci. 2023; 10:1106370.
PMID: 37006624
PMC: 10063971.
DOI: 10.3389/fmolb.2023.1106370.
Targeting histone methylation to reprogram the transcriptional state that drives survival of drug-tolerant myeloid leukemia persisters.
van Gils N, Verhagen H, Broux M, Martianez T, Denkers F, Vermue E
iScience. 2022; 25(9):105013.
PMID: 36097617
PMC: 9463578.
DOI: 10.1016/j.isci.2022.105013.
CRISPR-mediated MECOM depletion retards tumor growth by reducing cancer stem cell properties in lung squamous cell carcinoma.
Ma Y, Kang B, Li S, Xie G, Bi J, Li F
Mol Ther. 2022; 30(11):3341-3357.
PMID: 35733338
PMC: 9637721.
DOI: 10.1016/j.ymthe.2022.06.011.
Hematopoietic Stem Cell Factors: Their Functional Role in Self-Renewal and Clinical Aspects.
Mann Z, Sengar M, Verma Y, Rajalingam R, Raghav P
Front Cell Dev Biol. 2022; 10:664261.
PMID: 35399522
PMC: 8987924.
DOI: 10.3389/fcell.2022.664261.
PBX1: a key character of the hallmarks of cancer.
Veiga R, de Oliveira J, Gradia D
J Mol Med (Berl). 2021; 99(12):1667-1680.
PMID: 34529123
DOI: 10.1007/s00109-021-02139-2.
EVI1 dysregulation: impact on biology and therapy of myeloid malignancies.
Birdwell C, Fiskus W, Kadia T, DiNardo C, Mill C, Bhalla K
Blood Cancer J. 2021; 11(3):64.
PMID: 33753715
PMC: 7985498.
DOI: 10.1038/s41408-021-00457-9.
Myeloid neoplasms associated with t(3;12)(q26.2;p13) are clinically aggressive, show myelodysplasia, and frequently harbor chromosome 7 abnormalities.
Ronaghy A, Hu S, Tang Z, Wang W, Tang G, Loghavi S
Mod Pathol. 2020; 34(2):300-313.
PMID: 33110238
DOI: 10.1038/s41379-020-00663-z.
Oncogenic heterogeneous nuclear ribonucleoprotein D-like modulates the growth and imatinib response of human chronic myeloid leukemia CD34 cells via pre-B-cell leukemia homeobox 1.
Ji D, Zhang P, Ma W, Fei Y, Xue W, Wang Y
Oncogene. 2019; 39(2):443-453.
PMID: 31488872
DOI: 10.1038/s41388-019-0998-9.
EVI1 overexpression reprograms hematopoiesis via upregulation of Spi1 transcription.
Ayoub E, Wilson M, McGrath K, Li A, Frisch B, Palis J
Nat Commun. 2018; 9(1):4239.
PMID: 30315161
PMC: 6185954.
DOI: 10.1038/s41467-018-06208-y.
Loss of p53 induces leukemic transformation in a murine model of Jak2 V617F-driven polycythemia vera.
Tsuruta-Kishino T, Koya J, Kataoka K, Narukawa K, Sumitomo Y, Kobayashi H
Oncogene. 2017; 36(23):3300-3311.
PMID: 28068330
DOI: 10.1038/onc.2016.478.
The central nervous system microenvironment influences the leukemia transcriptome and enhances leukemia chemo-resistance.
Gaynes J, Jonart L, Zamora E, Naumann J, Gossai N, Gordon P
Haematologica. 2016; 102(4):e136-e139.
PMID: 28034988
PMC: 5395125.
DOI: 10.3324/haematol.2016.152926.
Internal Tandem Duplication in FLT3 Attenuates Proliferation and Regulates Resistance to the FLT3 Inhibitor AC220 by Modulating p21Cdkn1a and Pbx1 in Hematopoietic Cells.
Abe M, Pelus L, Singh P, Hirade T, Onishi C, Purevsuren J
PLoS One. 2016; 11(7):e0158290.
PMID: 27387666
PMC: 4936702.
DOI: 10.1371/journal.pone.0158290.
Expression of MECOM is associated with unfavorable prognosis in glioblastoma multiforme.
Hou A, Zhao L, Zhao F, Wang W, Niu J, Li B
Onco Targets Ther. 2016; 9:315-20.
PMID: 26834490
PMC: 4716764.
DOI: 10.2147/OTT.S95831.
EVI1 promotes tumor growth via transcriptional repression of MS4A3.
Heller G, Rommer A, Steinleitner K, Etzler J, Hackl H, Heffeter P
J Hematol Oncol. 2015; 8:28.
PMID: 25886616
PMC: 4389965.
DOI: 10.1186/s13045-015-0124-6.
Survivin modulates genes with divergent molecular functions and regulates proliferation of hematopoietic stem cells through Evi-1.
Fukuda S, Hoggatt J, Singh P, Abe M, Speth J, Hu P
Leukemia. 2014; 29(2):433-40.
PMID: 24903482
PMC: 4258188.
DOI: 10.1038/leu.2014.183.